Clinical Trials for Amrif

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Amrif

Clinical Trials (3)

NCT07085702
A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component Strep A Vaccine With Aluminum Hydroxide (Alum) or AS37 in Healthy Young Adults
PHASE1Recruiting
108 participants
Started: Jul 31, 2025 · Completed: Nov 30, 2026
1 condition5 sponsors2 locations
NCT07035769
A First-in-Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of Debio 1453P in Healthy Adults
PHASE1Recruiting
88 participants
Started: Jun 18, 2025 · Completed: May 31, 2026
1 condition6 sponsors1 location
NCT05480800
A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever
PHASE1/PHASE2Recruiting
155 participants
Started: Sep 13, 2022 · Completed: Dec 18, 2024
1 condition5 sponsors2 locations